OAKLAND, Calif., Aug. 31 /PRNewswire-FirstCall/ -- World Heart Corporation (WorldHeart) (Nasdaq: WHRT, TSX: WHT), a developer of mechanical circulatory support systems, today announced the appointment of Mr. David Pellone as Vice President, Finance and Chief Financial Officer. Mr. Richard Juelis, the departing CFO, will provide consulting services through the end of the year to assist with the transition and with certain specific projects.
Mr. Pellone is an experienced financial executive with a track record of success with technology companies. He has extensive experience as Vice President of Finance and Chief Financial Officer with a number of companies. His prior work experience includes Condor Power Supplies Incorporated, Flash Electronics Incorporated, RAE Systems Incorporated, AG Associates, Incorporated and the Medical Products and Services Division of 3M Corporation. He has also consulted with several companies, including WorldHeart, in areas ranging from public reporting to internal controls compliance.
"We are delighted to have David Pellone join WorldHeart as CFO. He brings a wealth of financial expertise to WorldHeart including experience with public technology companies," said Jal S. Jassawalla, WorldHeart's President and Chief Executive Officer. "I would like to thank Rich Juelis, personally and on behalf of WorldHeart, for his many contributions in completing and integrating the acquisition of MedQuest, the developer of our Levacor(TM) VAD, and the streamlining of operations and finance functions. We also look forward to his transitional assistance to WorldHeart."
World Heart Corporation is a developer of mechanical circulatory support systems with leading next-generation technologies, headquartered in Oakland, California, with additional facilities in Salt Lake City, Utah and in the Netherlands. WorldHeart's registered office is Ottawa, Ontario, Canada.
|SOURCE World Heart Corporation|
Copyright©2007 PR Newswire.
All rights reserved